期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

ERCP术后胰腺炎的预防

Prophylaxis of Post ERCP Pancreatits
下载PDF
导出
摘要 ERCP虽然是个相对安全的内镜操作，但它也会有严重甚至致命的并发症。比较多见的有胰腺炎、出血、感染及穿孔，其中以ERCP术后急性胰腺炎（PEP）最常见。发病率为5％左右，其中一部分的PEP是非常凶险的，其死亡率约为0．5％。本文就PEP的预防进行综述，主要涉及药物和支架。 ERCP is a relatively safe endoscopic procedure, however there is the potential for severe, life-threatening complications, Acute pancreatitis represents the most common complication after ERCP procedures; rate of about 5% is reported in most prospective studies involving non-selected patients, the reported mortality of this complication is about 0.5%. This review summarizes the prophylaxis of this disease.
作者 瞿昌晶 李治（综述） 叶古祥（审校）
机构地区 上海市杨浦区中心医院普外科
出处 《世界感染杂志》 2006年第3期276-278,285,共4页 World Journal of Infection
关键词 ERCP 急性胰腺炎 药物 支架 ERCP acute pancreatitis drug stent
分类号 R657.51 [医药卫生—外科学]
  • 相关文献

参考文献26

  • 1Pier Alberto Testoni. Pharmacological Prevention of Post-ERCP Pancreatitis: The Facts and the Fiction [J]. JOP. J Pancreas (Online),2004, 5(4): 171-178.
  • 2Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus [J].Gastrointest Endosc, 1991, 37: 383-393.
  • 3Garcfa-Cano Lizcano J, Gonzadez Martfn JA, Morillas Arino J, et al.Complicaciones de la colangiopancreatografia retrogradaendoscopica. Estudio en una unidad pequena de CPRE [J]. Rev Esp Enferm Dig, 2004, 96 (3): 163-173.
  • 4Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study[J].Gastrointest Endosc, 2001, 54: 425-434.
  • 5Dimitrios Arvanitidis, George K Anagnostopoulos, Dimitrios Giannopoulos, et al. Can Somatostatin Prevent Post-ERCP Pancreatitis? Results of a Randomized Controlled Trial[J]. J Gastroenterol Hepatol, 2004, 19(3): 278-282
  • 6Yael Waknine. Somatostatin Effective Prophylaxis for Post-ERCP Pancreatitis [J]. Gut, 2003, 52: 1768-1773.
  • 7Poon RT, Yeung C, Lo CM, et al. Prophylactic effect of somatostain on post-ERCP pancreatitis: a randomized controlled trial [J].Gastrointest Endosc, 1999, 49: 593-598.
  • 8Andriulli A, Leandro G, Niro G, et al. Pharmacological treatment can prevent pancreatic injury after ERCP: a meta-analysis [J].Gastrointest Endosc, 2000, 51 : 1-7.
  • 9Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography [J]. N Engl J Med, 1996, 335: 919-923.
  • 10Andriulli A, Solmi L, Loperfido S, et al. Somatostatin (SST) and gabexate (GM) are ineffective in preventing post-ERCP complications [J]. [Abstract]. Gastrointest Endosc, 2004, 59: AB 106.

二级参考文献43

  • 1Smithline A, Silverman W, Rogers D, Nisi R, Wiersma M,Jamidar P, Hawes R, Lehman G. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopicsphincterotomy-induced pancreatitis in high-risk patients [J].Gastrointest Endos
  • 2Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F,De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study [J]. Gastrointest En dosc,1998; 48(1):1
  • 3Cotton PB, Lehman G, Vennes JA, Geenen JE, Russell RCG, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus [J]. Gastrointest Endosc, 1991; 37 (3):383 - 393
  • 4Freeman ML, Disario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, Overby CS, Aas J, Ryan ME, Bochna GS, Shaw MJ, Snady HW, Erickson RV, Moore JP, Roel JP. Risk factors for post-ERCP pancreatitis: a prospective,multicenter study [J]. Gastrointest Endosc
  • 5Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, Minoli G, Crosta C, Comin U, Fertitta A, Prada A,Passoni GR, Testoni PA. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study [J]. Am J Gastroenterol, 2001; 96(2): 4
  • 6Sherman S, Earle FD, Bucksot L, Esber E, Pezzi J,Gottlieb K, Lehman G. Does leaving a main pancreatic duct stent in place reduced the incidence of precut biliary sphincterotomy(ES)-induced pancreatitis [J] ? Am J Gastroenterol, 1995;90(9):1 614
  • 7Meyerson SM, Geenen JE, Johnson GK, Catalano MF,Geenen DJ, Schmalz MJ Hogan WJ. Pancreatic duct stenting decreases the incidence of post-ERCP pancreatitis: a prospective randomized study [J]. Gastroenterology, 1998; 114(4):G1 967
  • 8Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD,Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction [J]. Gastroenterology, 1998;115(12):1518-1524
  • 9Patel R, Tarnasky PR, Hennessy WS, Hawes RH, Payne KM, Nelles SE, Cunningham JT, Cotton PB. Does stenting after pancreatic sphincterotomy reduced post-ERCP pancreatitis in patients with prior biliary sphincterotomy: preliminary results of a prospective ra
  • 10Fazel A, Quadri A, Catalano MF, Meyerson SM, Geenen JE. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study [J]. Gastrointest Endosc,2003; 57(3): 291 -294

共引文献30

世界感染杂志
2006年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部